Leukemia and Lymphoma Reviews Book

	Preface to the Series
	Haematological Differences between Chronic Granulocytic Leukaemia, Atypical Chronic Myeloid Leukaemia, and Chronic Myelomonocytic Leukaemia	1
	New Directions in the Biology and Therapy of Chronic Myeloid Leukemia
	Ph-Negative Chronic Myeloid Leukemia: The Nature of the Breakpoint Junctions and Mechanism of ABL Transposition	17
	The Role of Interferon in the Treatment of Chronic Myelogenous Leukemia: Results and Prospects	29
	Acute Leukemias with the t(4;11)(q21;q23)	41
	Trisomy 13 in Acute Leukemia	49
	Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia	55
	Cytogenetic Abnormalities in Childhood Acute Lymphoblastic Leukemia Correlates with Clinical Features and Treatment Outcome	63
	Molecular Mechanisms in the Evolution of Chronic Myelocytic Leukemia	79
	Cell Cycle Parameters as Biological Predictors of Prognosis in AML: A Review and Update of Cell Cycle Kinetics and Remission Induction/Duration in Acute Leukemia
	Prolymphocytic Leukemia: Malignancy of Activated B Cells with an Apoptosis-like Response to Anti-Human IgM Signal Transduction	97
	Interleukin-2 Receptor [beta] Chain in Leukemias and Lymphomas	103
	Platelet PDGF and TGF-[beta] Levels in Myeloproliferative Disorders	113
	Thymosin [beta]4 Gene Expression in Leukemic Cells	119
	Expression of P62, a Putative Collagen Receptor, on Human Megakaryocytic Leukemia Cells	127
	The Role of Interleukin-1 and Colony Stimulating Factors in the Biology of the Blasts of Acute Myeloblastic Leukemia	133
	Non-HLA-Restricted Cytotoxic Cells and Their Modulation in Acute Myelogenous Leukemia	139
	N-ras Mutations in Acute Myelogenous Leukemia: A Review of the Current Literature and an Update of the Southwest Oncology Group Experience	149
	Acid Phosphatase Isoenzyme Profiles in Acute and Chronic Leukemias	159
	Proliferating Cell Nuclear Antigen: A New Marker of Proliferation in Cancer	171
	Mechanisms of Interaction between Interferon Gamma and Antineoplastic Agents on Growth and Differentiation of Leukemic Cells: A Review	181
	Role of Interleukin-2 Activated MHC-Nonrestricted Lymphocytes in Antileukemia Activity and Therapy	191
	Splenic Lymphoma with Villous Lymphocytes	205
	Chromosome Analysis in the Management of Patients with Non-Hodgkin's Lymphoma	215
	Post-Transplantation Lymphoproliferative Disorder	223
	The Use of Myeloablative Therapy with Autologous Bone Marrow Transplantation in the Treatment of Follicular Lymphoma	233
	Lymphohistiocytic T-Cell Lymphoma and Peripheral T-Cell Lymphoma Associated with Haemophagocytic Syndrome: Two Recently Recognised Entities Which Mimic Malignant Histiocytosis	239
	Measurement of Proliferation Indices in Non Hodgkin's Lymphoma - Is It Useful	247
	Sinus Histiocytosis with Massive Lymphadenopathy	255
	Mastocytosis and Co-existent Non-Hodgkin's Lymphoma and Myeloproliferative Disorders	261
	HTLV-I Induced Extranodal Lymphomas	269
	Clinicopathological Spectrum of Epstein-Barr Virus-Associated T Cell Malignancies	279